The Role of Enterolysis and Tamoxifen in Encapsulating Peritoneal Sclerosis: A Successful Case

Detalhes bibliográficos
Autor(a) principal: Sousa,Círia Leandra Martins de
Data de Publicação: 2022
Outros Autores: Pereira,Pedro Manuel Reis, Francisco,José António Teixeira da Silva, Prata,Catarina, Castro,Rui Arlindo, Morgado,Teresa Margarida
Tipo de documento: Relatório
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692022000300180
Resumo: ABSTRACT Encapsulating peritoneal sclerosis (EPS) is a rare complication of peritoneal dialysis which mortality can reach 50%. The usual treatment involves suspension of the technique, medical treatment, and surgical enterolysis. We report the case of a 36-year-old female who undergone continuous ambulatory peritoneal dialysis without complications for 10 years. She presented at the emergency department with abdominal pain and a diagnosis of peritonitis was assumed. The patient developed a systemic inflammatory response, and her abdominal computer tomography (CT) scan showed multiple parietal calcifications. After multiple broad-spectrum antibiotics, an undetermined febrile syndrome persisted, and parenteral nutrition was started. An EPS diagnosis was established and treatment with tamoxifen was proposed. Exploratory laparoscopy was decided, and the intraoperative findings were consistent with EPS. The patient was submitted to extensive enterolysis. A clinical improvement led to a discharge after 60 days of hospitalization. After more than 30 months with tamoxifen, she remains on hemodialysis and doing well. There are no randomized controlled trials to guide EPS management and the following procedures are more difficult to decide, who makes these reports important to the reflection. We describe a case of successful treatment of EPS, with a very severe presentation. The management with enterolysis and tamoxifen contributed decisively to this outcome.
id RCAP_c41051bf450f88e9d25dc4b670c82f08
oai_identifier_str oai:scielo:S0872-01692022000300180
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str
spelling The Role of Enterolysis and Tamoxifen in Encapsulating Peritoneal Sclerosis: A Successful CasePeritoneal Dialysis/adverse effectsPeritoneal Fibrosis/diagnosisPeritoneal Fibrosis/etiologyPeritoneal Fibrosis/surgeryPeritoneal Fibrosis/therapyTamoxifen/therapeutic useABSTRACT Encapsulating peritoneal sclerosis (EPS) is a rare complication of peritoneal dialysis which mortality can reach 50%. The usual treatment involves suspension of the technique, medical treatment, and surgical enterolysis. We report the case of a 36-year-old female who undergone continuous ambulatory peritoneal dialysis without complications for 10 years. She presented at the emergency department with abdominal pain and a diagnosis of peritonitis was assumed. The patient developed a systemic inflammatory response, and her abdominal computer tomography (CT) scan showed multiple parietal calcifications. After multiple broad-spectrum antibiotics, an undetermined febrile syndrome persisted, and parenteral nutrition was started. An EPS diagnosis was established and treatment with tamoxifen was proposed. Exploratory laparoscopy was decided, and the intraoperative findings were consistent with EPS. The patient was submitted to extensive enterolysis. A clinical improvement led to a discharge after 60 days of hospitalization. After more than 30 months with tamoxifen, she remains on hemodialysis and doing well. There are no randomized controlled trials to guide EPS management and the following procedures are more difficult to decide, who makes these reports important to the reflection. We describe a case of successful treatment of EPS, with a very severe presentation. The management with enterolysis and tamoxifen contributed decisively to this outcome.Sociedade Portuguesa de Nefrologia2022-09-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/reporttext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692022000300180Portuguese Journal of Nephrology & Hypertension v.36 n.3 2022reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692022000300180Sousa,Círia Leandra Martins dePereira,Pedro Manuel ReisFrancisco,José António Teixeira da SilvaPrata,CatarinaCastro,Rui ArlindoMorgado,Teresa Margaridainfo:eu-repo/semantics/openAccess2023-07-27T12:22:35ZPortal AgregadorONG
dc.title.none.fl_str_mv The Role of Enterolysis and Tamoxifen in Encapsulating Peritoneal Sclerosis: A Successful Case
title The Role of Enterolysis and Tamoxifen in Encapsulating Peritoneal Sclerosis: A Successful Case
spellingShingle The Role of Enterolysis and Tamoxifen in Encapsulating Peritoneal Sclerosis: A Successful Case
Sousa,Círia Leandra Martins de
Peritoneal Dialysis/adverse effects
Peritoneal Fibrosis/diagnosis
Peritoneal Fibrosis/etiology
Peritoneal Fibrosis/surgery
Peritoneal Fibrosis/therapy
Tamoxifen/therapeutic use
title_short The Role of Enterolysis and Tamoxifen in Encapsulating Peritoneal Sclerosis: A Successful Case
title_full The Role of Enterolysis and Tamoxifen in Encapsulating Peritoneal Sclerosis: A Successful Case
title_fullStr The Role of Enterolysis and Tamoxifen in Encapsulating Peritoneal Sclerosis: A Successful Case
title_full_unstemmed The Role of Enterolysis and Tamoxifen in Encapsulating Peritoneal Sclerosis: A Successful Case
title_sort The Role of Enterolysis and Tamoxifen in Encapsulating Peritoneal Sclerosis: A Successful Case
author Sousa,Círia Leandra Martins de
author_facet Sousa,Círia Leandra Martins de
Pereira,Pedro Manuel Reis
Francisco,José António Teixeira da Silva
Prata,Catarina
Castro,Rui Arlindo
Morgado,Teresa Margarida
author_role author
author2 Pereira,Pedro Manuel Reis
Francisco,José António Teixeira da Silva
Prata,Catarina
Castro,Rui Arlindo
Morgado,Teresa Margarida
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Sousa,Círia Leandra Martins de
Pereira,Pedro Manuel Reis
Francisco,José António Teixeira da Silva
Prata,Catarina
Castro,Rui Arlindo
Morgado,Teresa Margarida
dc.subject.por.fl_str_mv Peritoneal Dialysis/adverse effects
Peritoneal Fibrosis/diagnosis
Peritoneal Fibrosis/etiology
Peritoneal Fibrosis/surgery
Peritoneal Fibrosis/therapy
Tamoxifen/therapeutic use
topic Peritoneal Dialysis/adverse effects
Peritoneal Fibrosis/diagnosis
Peritoneal Fibrosis/etiology
Peritoneal Fibrosis/surgery
Peritoneal Fibrosis/therapy
Tamoxifen/therapeutic use
description ABSTRACT Encapsulating peritoneal sclerosis (EPS) is a rare complication of peritoneal dialysis which mortality can reach 50%. The usual treatment involves suspension of the technique, medical treatment, and surgical enterolysis. We report the case of a 36-year-old female who undergone continuous ambulatory peritoneal dialysis without complications for 10 years. She presented at the emergency department with abdominal pain and a diagnosis of peritonitis was assumed. The patient developed a systemic inflammatory response, and her abdominal computer tomography (CT) scan showed multiple parietal calcifications. After multiple broad-spectrum antibiotics, an undetermined febrile syndrome persisted, and parenteral nutrition was started. An EPS diagnosis was established and treatment with tamoxifen was proposed. Exploratory laparoscopy was decided, and the intraoperative findings were consistent with EPS. The patient was submitted to extensive enterolysis. A clinical improvement led to a discharge after 60 days of hospitalization. After more than 30 months with tamoxifen, she remains on hemodialysis and doing well. There are no randomized controlled trials to guide EPS management and the following procedures are more difficult to decide, who makes these reports important to the reflection. We describe a case of successful treatment of EPS, with a very severe presentation. The management with enterolysis and tamoxifen contributed decisively to this outcome.
publishDate 2022
dc.date.none.fl_str_mv 2022-09-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/report
format report
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692022000300180
url http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692022000300180
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692022000300180
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Nefrologia
publisher.none.fl_str_mv Sociedade Portuguesa de Nefrologia
dc.source.none.fl_str_mv Portuguese Journal of Nephrology & Hypertension v.36 n.3 2022
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1777304402363678720